However, the lack of consistent improvement in bone turnover markers (such as osteocalcin and P1NP) across studies points to variability in individual responses, potentially due to age, sex, disease duration, glucocorticoid co-treatment, or hormonal status
Autoimmune gastritis: update and new perspectives in therapeutic management
These figures reflect reported experimental handling only and are provided strictly for research use, not for human use
Deferoxamine, the first FDA-approved drug in 1968 (Parker et al., 2023), is administered via intravenous (IV) or intramuscular (IM) injection due to its poor oral bioavailability, which is one of the most significant limitations of the DFO treatment (Entezari et al., 2022)
Reconstitution and handling Wolverine is supplied as a lyophilised vial and should be handled using standard peptide reconstitution procedures appropriate to the research setting